A new study suggests that a father’s COVID-19 infection could do more than make him sick – it may leave marks on his sperm ...

QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.

A higher proportion of adolescents who tested positive for COVID-19 reported ongoing symptoms compared with those who tested negative or never tested.

News24 brings you the top stories of the day, summarised into neat little packages. Read through quickly or listen to the ...

The appointments of new heads for the NPA and SARS will unquestionably provide a very clear answer as to whether any form of ...

QuidelOrtho Corporation recently expanded its QUICKVUE portfolio with the launch of the QUICKVUE Influenza + SARS Test, a rapid, CLIA-waived immunoassay for professional use that delivers simultaneous ...

Drugmaker Roche on Friday said it had received Emergency Use Authorization from the U.S. Food and Drug Administration for a test to quickly detect whether a patient has SARS-CoV-2 or one of two forms ...

SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...

"Physician office labs and urgent care centers are on the front lines of respiratory illness diagnosis. With the QUICKVUE Influenza + SARS Test, we're equipping healthcare providers with a reliable, ...

Researchers discuss the effects of azelastine nasal spray on the rate of SARS-CoV-2 infection as compared to placebo.

Italian franchising group WM Capital said on Monday it had received a mandate from China's Xiamen Boson Biotech for the distribution in Italy of the Rapid Sars-CoV-2 Antigen Test for a quick diagnosis ...